幼儿结核病诊断的敏感可行标本采集与检测策略
这项在肯尼亚开展的前瞻性横断面诊断研究纳入300名5岁以下疑似结核病儿童,以最多6种标本类型各2份的Xpert MTB/RIF和MGIT培养组合为参考标准,评估不同微创标本组合的敏感性。结果显示,鼻咽 aspirate(NPA)双份或与粪便/尿液组合的敏感性(74%、71%、69%)与参考标准标本(胃 aspirate 77%、诱导痰 64%)相近,而胃 aspirate 联合 NPA 的平均产量达90%。
要点
- NPA双份或联合粪便/尿液标本的敏感性接近胃 aspirate 和诱导痰等参考标准标本。
- 胃 aspirate 联合 NPA 的产量高于当前参考标准,可能适用于特定临床和研究场景。
- 在资源有限地区,NPA等微创标本可改善幼儿结核病诊断。
核心结论
- NPA双份或与粪便或尿液标本组合易于获取,诊断产量与参考标准标本相当。
- 胃 aspirate 联合 NPA 的产量高于当前参考标准,可能在某些临床和研究场景中有用。
研究设计与样本
- 参考标准为最多6种标本类型各2份样本,分别用Xpert MTB/RIF和MGIT培养检测结核分枝杆菌复合群。
- 共纳入300名儿童,中位年龄2.0岁(IQR 1.0-3.6),女性151名(50.3%),294名符合分析标准。
主要发现
- 31名确诊结核儿童中,最多2份胃 aspirate 阳性24例(敏感性77%,interdecile range 68%-87%),最多2份诱导痰阳性20例(敏感性64%,interdecile range 53%-76%)。
- 2份NPA阳性23例(敏感性74%,interdecile range 64%-84%),1份NPA+1份粪便阳性22例(敏感性71%,interdecile range 60%-81%),1份NPA+1份尿液阳性21.5例(敏感性69%,interdecile range 58%-80%)。
- 最多2份胃 aspirate 联合最多2份NPA的平均产量为90%(28/31)。
临床怎么用
- 在资源有限地区,可优先考虑采集NPA(双份)或NPA联合粪便/尿液标本进行结核病诊断,因其微创且产量与参考标准相近。
- 在特定临床或研究场景中,可考虑胃 aspirate 联合 NPA 以提高诊断产量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Criterion-standard specimens for tuberculosis diagnosis in young children, gastric aspirate (GA) and induced sputum, are invasive and rarely collected in resource-limited settings. A far less invasive approach to tuberculosis diagnostic testing in children younger than 5 years as sensitive as current reference standards is important to identify. OBJECTIVE: To characterize the sensitivity of preferably minimally invasive specimen and assay combinations relative to maximum observed yield from all specimens and assays combined. DESIGN, SETTING, AND PARTICIPANTS: In this prospective cross-sectional diagnostic study, the reference standard was a panel of up to 2 samples of each of 6 specimen types tested for Mycobacterium tuberculosis complex by Xpert MTB/RIF assay and mycobacteria growth indicator tube culture. Multiple different combinations of specimens and tests were evaluated as index tests. A consecutive series of children was recruited from inpatient and outpatient settings in Kisumu County, Kenya, between October 2013 and August 2015. Participants were children younger than 5 years who had symptoms of tuberculosis (unexplained cough, fever, malnutrition) and parenchymal abnormality on chest radiography or who had cervical lymphadenopathy. Children with 1 or more evaluable specimen for 4 or more primary study specimen types were included in the analysis. Data were analyzed from February 2015 to October 2020. MAIN OUTCOMES AND MEASURES: Cumulative and incremental diagnostic yield of combinations of specimen types and tests relative to the maximum observed yield. RESULTS: Of the 300 enrolled children, the median (interquartile range) age was 2.0 (1.0-3.6) years, and 151 (50.3%) were female. A total of 294 met criteria for analysis. Of 31 participants with confirmed tuberculosis (maximum observed yield), 24 (sensitivity, 77%; interdecile range, 68%-87%) had positive results on up to 2 GA samples and 20 (sensitivity, 64%; interdecile range, 53%-76%) had positive test results on up to 2 induced sputum samples. The yields of 2 nasopharyngeal aspirate (NPA) samples (23 of 31 [sensitivity, 74%; interdecile range, 64%-84%]), of 1 NPA sample and 1 stool sample (22 of 31 [sensitivity, 71%; interdecile range, 60%-81%]), or of 1 NPA sample and 1 urine sample (21.5 of 31 [sensitivity, 69%; interdecile range, 58%-80%]) were similar to reference-standard specimens. Combining up to 2 each of GA and NPA samples had an average yield of 90% (28 of 31). CONCLUSIONS AND RELEVANCE: NPA, in duplicate or in combination with stool or urine specimens, was readily obtainable and had diagnostic yield comparable with reference-standard specimens. This combination could improve tuberculosis diagnosis among children in resource-limited settings. Combining GA and NPA had greater yield than that of the current reference standards and may be useful in certain clinical and research settings.
引用
- Song R, Click ES, McCarthy KD, et al. Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children. JAMA Pediatr. 2021. PMID: 33616611. doi:10.1001/jamapediatrics.2020.6069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。